Impact Capital Partners LLC Grows Holdings in Exponent, Inc. (NASDAQ:EXPO)

Impact Capital Partners LLC increased its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 10.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,677 shares of the business services provider’s stock after buying an additional 424 shares during the period. Impact Capital Partners LLC’s holdings in Exponent were worth $379,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in EXPO. Private Trust Co. NA increased its stake in shares of Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider’s stock valued at $25,000 after buying an additional 157 shares during the period. Atala Financial Inc purchased a new position in shares of Exponent during the fourth quarter valued at $25,000. Whipplewood Advisors LLC increased its stake in shares of Exponent by 5,333.3% during the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider’s stock valued at $26,000 after buying an additional 320 shares during the period. Tortoise Investment Management LLC increased its stake in shares of Exponent by 76.7% during the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider’s stock valued at $39,000 after buying an additional 191 shares during the period. Finally, Brown Brothers Harriman & Co. purchased a new position in shares of Exponent during the fourth quarter valued at $50,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Trading Up 0.3%

Shares of Exponent stock opened at $77.41 on Friday. The firm has a market cap of $3.93 billion, a P/E ratio of 36.51 and a beta of 0.92. Exponent, Inc. has a 12 month low of $73.37 and a 12 month high of $115.75. The stock’s fifty day moving average price is $78.09 and its 200-day moving average price is $85.49.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The firm had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. During the same quarter last year, the firm posted $0.59 earnings per share. The business’s revenue for the quarter was up .2% on a year-over-year basis. Analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Friday, June 6th. Exponent’s payout ratio is currently 58.54%.

Insider Activity at Exponent

In related news, VP John Pye sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total transaction of $152,640.00. Following the sale, the vice president now owns 29,204 shares of the company’s stock, valued at $2,228,849.28. This trade represents a 6.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Joseph Rakow sold 1,573 shares of the firm’s stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total value of $122,253.56. The disclosure for this sale can be found here. Insiders have sold a total of 6,267 shares of company stock valued at $489,120 over the last quarter. 2.10% of the stock is owned by corporate insiders.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.